Nippon Shinyaku Company, Ltd.

Akira Nomura

Hiroshi Enomoto

Yoshiaki Aoyagi

Fusao Ueda

Masanobu Kawamata

Yoshihisa Shibata

2,4-diamino-6-(2,5-dichlorophenyl)-1,3,5-triazine and pharmaceutically acceptable acid addition salts thereof in finely pulverized form so that the average particle diameter is 20 microns or less have been found to be particularly useful for the treatment of peptic ulcers. When administered to humans in need thereof, 1 to 4 mg per day has been found effective.

Low dosage compositions of finely pulverized

2,4-Diamino-6-(2,5-dichlorophenyl)-1,3,5-triazine and pharmaceutically acceptable acid addition salts thereof in finely pulverized form so that the average particle diameter is 20 microns or less have been found to be particularly useful for the treatment of peptic ulcers.

Finely pulverized 2,4-diamino-6-(2,5-dichloro-phenyl)-1,3,5-triazine and

A method of prevention and/or treatment of disorders of the liver, kidney, colon or rectum in mammals including humans which comprises administering to the patient a therapeutically effective amount of 2,4-diamino-6-(2',5-dichlorophenyl)-s-triazine maleate sufficient to prevent and/or overcome said disorders, and pharmaceutical compositions therefor.

Treatment of diseases of the liver, kidney, colon and rectum

Compounds useful in the treatment of rheumatism or allergic nephritis which have the formula ##STR1## wherein X is halogen, hydroxy, lower alkyl, lower alkenyl, lower alkoxy, nitro or amino;

Growing community of inventors

Hirakata, Japan

Akira Nomura